We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$121M
AUM Growth
-$4.02M
Cap. Flow
-$6.69M
Cap. Flow %
-5.54%
Top 10 Hldgs %
48.15%
Holding
84
New
10
Increased
18
Reduced
47
Closed
7

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$1.62M
2
GILD icon
Gilead Sciences
GILD
+$1.35M
3
INSM icon
Insmed
INSM
+$1.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.23M
5
MDT icon
Medtronic
MDT
+$1.06M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$1.4M
2
AMGN icon
Amgen
AMGN
+$1.38M
3
ABBV icon
AbbVie
ABBV
+$1.02M
4
CTNM
Contineum Therapeutics
CTNM
+$982K
5
LLY icon
Eli Lilly
LLY
+$935K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
51
Ionis Pharmaceuticals
IONS
$8.99B
$617K 0.51%
7,200
-1,165
-14% -$91.9K
BMRN icon
52
BioMarin Pharmaceuticals
BMRN
$11.5B
$607K 0.5%
9,450
-1,430
-13% -$83.4K
KURA icon
53
Kura Oncology
KURA
$964M
$606K 0.5%
71,480
+17,370
+32% +$149K
PRVA icon
54
Privia Health
PRVA
$3.39B
$558K 0.46%
27,136
+1,136
+4% +$25.6K
CYTK icon
55
Cytokinetics
CYTK
$10.9B
$545K 0.45%
7,300
+1,407
+24% +$89.4K
PTCT icon
56
PTC Therapeutics
PTCT
$6.52B
$515K 0.43%
6,650
-1,065
-14% -$75.4K
QURE icon
57
uniQure
QURE
$2.77B
$499K 0.41%
29,245
-1,340
-4% -$27.1K
AGMB
58
AgomAb Therapeutics NV
AGMB
$593M
$477K 0.4%
+43,500
New +$616K
ALHC icon
59
Alignment Healthcare
ALHC
$4.26B
$474K 0.39%
26,911
-4,589
-15% -$92.2K
HNGE
60
Hinge Health
HNGE
$6.74B
$472K 0.39%
12,244
-1,962
-14% -$81.5K
RDNT icon
61
RadNet
RDNT
$4.89B
$447K 0.37%
7,999
-3,001
-27% -$205K
RPRX icon
62
Royalty Pharma
RPRX
$25.8B
$394K 0.33%
7,200
-1,270
-15% -$55.6K
BIIB icon
63
Biogen
BIIB
$30.4B
$386K 0.32%
1,850
-305
-14% -$56.2K
INSP icon
64
Inspire Medical Systems
INSP
$1.46B
$373K 0.31%
7,225
+25
+0.3% +$1.75K
JAZZ icon
65
Jazz Pharmaceuticals
JAZZ
$15.5B
$371K 0.31%
1,750
-299
-15% -$52.3K
NBIX icon
66
Neurocrine Biosciences
NBIX
$17.2B
$344K 0.28%
2,300
-375
-14% -$49.8K
ORIC icon
67
Oric Pharmaceuticals
ORIC
$1.11B
$333K 0.28%
23,500
+1,020
+5% +$11.6K
OMDA
68
Omada Health Inc
OMDA
$1.41B
$322K 0.27%
25,620
-10,880
-30% -$150K
ABVX
69
Abivax
ABVX
$11.9B
$298K 0.25%
+2,340
New +$277K
ILMN icon
70
Illumina
ILMN
$28.2B
$296K 0.25%
2,132
-340
-14% -$44.6K
AXSM icon
71
Axsome Therapeutics
AXSM
$11.8B
$290K 0.24%
1,500
-240
-14% -$41.5K
INCY icon
72
Incyte
INCY
$23.4B
$254K 0.21%
2,350
-400
-15% -$39.9K
MRNA icon
73
Moderna
MRNA
$24.5B
$248K 0.21%
4,350
-655
-13% -$30.6K
MEDP icon
74
Medpace
MEDP
$15.4B
$228K 0.19%
+430
New +$220K
GH icon
75
Guardant Health
GH
$20.7B
$206K 0.17%
+1,980
New +$199K
1 2
3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
FWA
Fulcrum Wealth Advisors Bellevue, Washington $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM

Sectoral Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Sectoral Asset Management held 84 positions worth $121M, down 3.2% from $125M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sectoral Asset Management withdrew a net $6.69M in Q1 2026, closing 7 positions and reducing 47 holdings. Its most notable exit was AstraZeneca, an estimated $1.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in IQVIA worth $1.42M.

  • Sectoral Asset Management's largest Q1 2026 buy was IQVIA: 8,307 shares worth $1.42M.
  • Sectoral Asset Management added most to Gilead Sciences in Q1 2026, an estimated $1.35M increase.
  • Sectoral Asset Management's biggest Q1 2026 reduction was Amgen, cutting an estimated $1.38M.
  • Sectoral Asset Management fully exited AstraZeneca in Q1 2026, selling an estimated $1.4M.
  • Sectoral Asset Management's ten largest holdings make up 48% of its $121M portfolio in Q1 2026.
  • Sectoral Asset Management opened 10 new positions and closed 7 in Q1 2026.
  • Sectoral Asset Management's portfolio value fell 3.2% quarter-over-quarter to $121M.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.